Growth Metrics

Veon (VEON) EBITDA Margin (2016 - 2025)

Veon has reported EBITDA Margin over the past 15 years, most recently at 75.44% for Q2 2025.

  • For Q2 2025, EBITDA Margin rose 4837.0% year-over-year to 75.44%; the TTM value through Jun 2025 reached 36.37%, up 513.0%, while the annual FY2025 figure was 45.85%, 492.0% up from the prior year.
  • EBITDA Margin was 75.44% for Q2 2025 at Veon, up from 24.33% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 75.44% in Q2 2025 and bottomed at 5.51% in Q4 2021.
  • The 5-year median for EBITDA Margin is 23.98% (2022), against an average of 28.92%.
  • Year-over-year, EBITDA Margin crashed -1289bps in 2021 and then surged 4837bps in 2025.
  • Over 5 years, EBITDA Margin stood at 5.51% in 2021, then skyrocketed by 329bps to 23.64% in 2022, then grew by 12bps to 26.42% in 2023, then dropped by -8bps to 24.33% in 2024, then skyrocketed by 210bps to 75.44% in 2025.
  • The last three reported values for EBITDA Margin were 75.44% (Q2 2025), 24.33% (Q4 2024), and 27.07% (Q2 2024) per Business Quant data.